OCOEE, FL, Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ: ICCT), a leading cloud-based Software-as-a-Service (SaaS) company specializing in enterprise and healthcare workflow solutions, has announced the appointment of Yvonne Hyland to its Board of Directors. With over 30 years of experience in the global technology industry, Yvonne Hyland has held leadership positions in both startups and Fortune 100 companies. Her impressive career includes key roles at SAP and Gartner, as well as founding ...

OCOEE, FL, Sept. 09, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ: ICCT), a leading provider of cloud-based software and technology solutions, has announced an expanded partnership with the Mississippi Dental Association (MDA). The MDA now endorses seven of iCoreConnect’s products, broadening its initial endorsement of the company’s cloud-based electronic prescribing software. In 2020, the MDA began endorsing iCoreConnect’s iCoreRx software, including its Electronic Prescribing for Controlled Substanc ...

OCOEE, FL, Aug. 28, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ: ICCT) ("iCore" or the "Company"), a leading provider of cloud-based software and technology solutions, is pleased to announce a new partnership with the Alaska Dental Society (ADS). The ADS has officially endorsed nine of iCoreConnect’s products, further expanding iCoreConnect’s presence across the nation. With this endorsement, the Alaska Dental Society joins a growing list of state dental associations that recognize the value of iCore ...

公司基本信息 - 公司股票在纳斯达克股票市场交易，股票代码为ICCT[6] - 公司电话号码为(888) 810-7706，包括区号[5] - 公司地址位于529 Crown Point Road, Suite 250, Ocoee, FL 34761[4] - 公司为新兴增长公司，符合规则405和12b-2的定义[7] - 公司未选择使用延长过渡期以遵守新的或修订的财务会计标准[8] 财务报告相关 - 公司发布2024年8月16日的财务报告，涵盖截至2024年6月30日的六个月和三个月的财务结果[9] - 公司提交的Form 8-K包括Exhibit 99.1，但不视为“提交”文件，不纳入任何注册声明或其他文件[10] - 公司财务报告和相关展示文件包含在Exhibit 99.1中[11] - 公司报告由总裁兼首席执行官Robert McDermott签署，日期为2024年8月16日[14]

OCOEE, FL , Aug. 16, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ: ICCT) ("iCore" or the "Company"), a leading provider of cloud-based software and technology solutions designed to enhance workflow productivity and customer profitability, is pleased to announce its financial results for the three and six months ended June 30, 2024. Q2 2024 Financial Highlights Revenue Growth: The Company reported a significant 66% increase in revenue, rising from $1.6 million in Q2 2023 to $3.1 million in Q2 2024. For ...

财务表现 - 总收入同比增长57%至5,811,263美元[267] - 毛利率为81%，较上年同期的73%有所提升[269] - 订阅软件和服务收入的增长率高于专业服务和其他收入，带动了毛利率的提升[269] - 净亏损为1,561.8万美元，较上年同期增加180%[1] - 归属于普通股股东的净亏损为1,651.4万美元，较上年同期增加206%[1] - 收入增加至581.1万美元，较上年同期增加57%[2] - 销售成本增加15%至111.9万美元[3] - 销售、一般及管理费用增加145%至1,370.7万美元，主要由于一次性股权激励费用477.9万美元[4] - 折旧和摊销费用增加161%至151.4万美元，主要由于并购资产的摊销增加[5] - 利息费用增加38%至72.8万美元，主要由于借款总额增加[6] - 融资费用增加408%至214.4万美元，主要由于取消股权融资额度而冲销递延费用100.8万美元[7] 业务发展 - 公司继续获得云端SaaS产品的良好市场反响[273] - 公司与大型医疗机构和保险公司达成合作协议[274] 融资情况 - 公司在2024年上半年通过发行有担保债券和可转换债券筹集了2,927,960美元资金[275] - 优先股股息为89.6万美元[1] - 远期购买协议公允价值变动产生净费用216.3万美元[8]

Strategic Partnership Enhances Patient Engagement Platform with Advanced iCoreRx ePrescribing Software OCOEE, FL, Aug. 05, 2024 (GLOBE NEWSWIRE) -- iCoreConnect Inc. (NASDAQ:ICCT) ("iCore" or the "Company"), a leading cloud-based software and technology company, today announced a new reseller agreement with mConsent, a leader in digital patient intake, patient communication and engagement solutions. Through this partnership, mConsent will now offer iCoreConnect's premier electronic prescribing software, iCo ...

公司概况 - iCoreConnect, Inc. 是一家新兴增长型公司[2] 领导团队 - Robert McDermott 是 iCoreConnect, Inc. 的总裁兼首席执行官[4] 财务业绩 - iCoreConnect, Inc. 于2024年3月31日结束的三个月内发布了财务业绩[2]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-41309 iCoreConnect Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 86-2462502 (State or other jurisdiction of (I.R.S. ...

New Endorsements Allows iCoreConnect New Entry Into the Tennessee Market OCOEE, FL, April 23, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- iCoreConnect Inc. (NASDAQ:ICCT)("iCore" or the "Company"), a leading cloud-based software and SaaS technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform, announced today the endorsement of the Tennessee Dental Association for seven of iCoreConnect's solutions. This strategic colla ...